{"id":"https://openalex.org/W4361850065","doi":"https://doi.org/10.1158/0008-5472.22408860.v1","title":"Supplementary Figure 3 from Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival","display_name":"Supplementary Figure 3 from Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4361850065","doi":"https://doi.org/10.1158/0008-5472.22408860.v1"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.22408860.v1","doi":"https://doi.org/10.1158/0008-5472.22408860.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22408860.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/0008-5472.22408860.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079027078","display_name":"Petra den Hollander","orcid":"https://orcid.org/0000-0002-4272-1231","observed_orcids":["https://orcid.org/0000-0002-4272-1231"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Petra den Hollander","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047239145","display_name":"Kathryn Rawls","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kathryn Rawls","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080914070","display_name":"Anna I. Tsimelzon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Tsimelzon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Jonathan Shepherd","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonathan Shepherd","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081500324","display_name":"Abhijit Mazumdar","orcid":"https://orcid.org/0000-0002-8174-1251","observed_orcids":["https://orcid.org/0000-0002-8174-1251"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abhijit Mazumdar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043733113","display_name":"Jamal L. Hill","orcid":"https://orcid.org/0000-0002-7828-9647","observed_orcids":["https://orcid.org/0000-0002-7828-9647"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jamal Hill","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054255756","display_name":"Suzanne A.W. Fuqua","orcid":"https://orcid.org/0000-0001-8886-5161","observed_orcids":["https://orcid.org/0000-0001-8886-5161"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suzanne A.W. Fuqua","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025409813","display_name":"Jenny C. Chang","orcid":"https://orcid.org/0000-0002-0890-9302","observed_orcids":["https://orcid.org/0000-0002-0890-9302"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jenny C. Chang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037774999","display_name":"Charles Kent Osborne","orcid":"https://orcid.org/0000-0002-0044-618X","observed_orcids":["https://orcid.org/0000-0002-0044-618X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Kent Osborne","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073398031","display_name":"Susan Galloway Hilsenbeck","orcid":"https://orcid.org/0000-0002-7962-673X","observed_orcids":["https://orcid.org/0000-0002-7962-673X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susan G. Hilsenbeck","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005221518","display_name":"Gordon Brent Mills","orcid":"https://orcid.org/0000-0002-0144-9614","observed_orcids":["https://orcid.org/0000-0002-0144-9614"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gordon B. Mills","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5069756775","display_name":"Powel H. Brown","orcid":"https://orcid.org/0000-0002-3398-163X","observed_orcids":["https://orcid.org/0000-0002-3398-163X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Powel H. Brown","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12620","display_name":"Signaling Pathways in Disease","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ptp4a3","display_name":"PTP4A3","score":0.9950000047683716},{"id":"https://openalex.org/keywords/phosphatase","display_name":"phosphatase","score":0.8610000014305115},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tumor-growth","display_name":"tumor growth","score":0.9419999718666077},{"id":"https://openalex.org/keywords/doxycycline","display_name":"doxycycline","score":0.9589999914169312},{"id":"https://openalex.org/keywords/shrna-knockdown","display_name":"shRNA knockdown","score":0.7450000047683716},{"id":"https://openalex.org/keywords/mda-mb-231-cells","display_name":"MDA-MB-231 cells","score":0.9449999928474426},{"id":"https://openalex.org/keywords/mda-mb-468-cells","display_name":"MDA-MB-468","score":0.9789999723434448},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.9900000095367432},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.8740000128746033},{"id":"https://openalex.org/keywords/patient-survival","display_name":"patient survival","score":0.7170000076293945}],"concepts":[{"id":"https://openalex.org/C2777179404","wikidata":"https://www.wikidata.org/wiki/Q422442","display_name":"Doxycycline","level":3,"score":0.8794872760772705},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.7765213251113892},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5849867463111877},{"id":"https://openalex.org/C2986637895","wikidata":"https://www.wikidata.org/wiki/Q953865","display_name":"Breast tumor","level":4,"score":0.47199252247810364},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43434834480285645},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3994954228401184},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35741856694221497},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3489980399608612},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3215762972831726},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18593594431877136},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.0},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.22408860.v1","doi":"https://doi.org/10.1158/0008-5472.22408860.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22408860.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.22408860.v1","doi":"https://doi.org/10.1158/0008-5472.22408860.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22408860.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1568111271","https://openalex.org/W4361817643","https://openalex.org/W2287812034","https://openalex.org/W1968994582","https://openalex.org/W6903930666","https://openalex.org/W4221127082","https://openalex.org/W3083056762","https://openalex.org/W4322771485","https://openalex.org/W6920893696","https://openalex.org/W6921152228"],"abstract_inverted_index":{"Supp":[0],"Fig":[1],"3":[2],"-":[3],"A-B)":[4],"Average":[5,37],"tumor":[6,38],"growth":[7,39,55,70],"of":[8,23,40,72],"MDA":[9,24,41],"MB231":[10,25],"shPTP4A3":[11],"and":[12,28,45,76],"control":[13,26,43,74],"tumors":[14,27,30,44,47,61,75,78],"treated":[15,31,48,79],"with":[16,32,49,80],"doxycycline":[17,33,50,81],"or":[18,34,51,82],"vehicle.":[19,35,52,83],"C)":[20],"mRNA":[21],"expression":[22],"PTP4A3":[29,46,77],"D)":[36,53],"MB468":[42],"Tumor":[54,69],"rate":[56],"is":[57],"not":[58],"reduced":[59],"in":[60],"from":[62],"the":[63],"ER-positive":[64],"breast":[65],"cancer":[66],"cell":[67],"lines.E).":[68],"slopes":[71],"MCF-7":[73]},"counts_by_year":[],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2023-04-05T00:00:00"}